Skip to content

Opening book details…

About this Medicine article

4P IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+ T-cells by Ugolini, A. ;Zizzari, I.G. ;Ceccarelli, F. ;Botticelli, A. ;Colasanti, T. ;Strigari, L. ;Rughetti, A. ;Rahimi, H. ;Conti, F. ;Valesini, G. ;Marchetti, P. ;Nuti, M. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Ugolini, A. ;Zizzari, I.G. ;Ceccarelli, F. ;Botticelli, A. ;Colasanti, T. ;Strigari, L. ;Rughetti, A. ;Rahimi, H. ;Conti, F. ;Valesini, G. ;Marchetti, P. ;Nuti, M.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2020
Field
Medicine (Health Sciences)

More by Ugolini, A. ;Zizzari, I.G. ;Ceccarelli, F. ;Botticelli, A. ;Colasanti, T. ;Strigari, L. ;Rughetti, A. ;Rahimi, H. ;Conti, F. ;Valesini, G. ;Marchetti, P. ;Nuti, M.

Browse all works by Ugolini, A. ;Zizzari, I.G. ;Ceccarelli, F. ;Botticelli, A. ;Colasanti, T. ;Strigari, L. ;Rughetti, A. ;Rahimi, H. ;Conti, F. ;Valesini, G. ;Marchetti, P. ;Nuti, M.